Thus, the decreased IL‐2 levels, potentially driven by changes in PRKG1, seen in individuals with diabetes and COVID‐19 may impair this immune mechanism, predisposing individuals with diabetes to worsened immune responses. Here, IL2 is linked to COVID-19.